Year: 2026
Type: article
Abstract: Aberrant endocytosis has long been associated with epithelial plasticity and tumorigenesis, but direct in vivo evidence of its causal role in tumor progression and metastasis has been lacking. Here, we identify and molecularly characterize a previously unrecognized form of E-cadherin (ECAD) internalization in mammary epithelial cells. This process is n mediated by the endocytic adapter Epsin 3 (EPN3) through glycolipid-lectin (GL-Lect)-driven endocytosis requiring galectin-3 and Eps15-family adapters. We further define the molecular basis of this pathway, identifying EPN3-specific interaction surfaces that promote ECAD clustering and galectin-3 recruitment, thereby driving clathrin-independent ECAD internalization. Leveraging an EPN3 knock-in mouse model, we show that dysregulation of GL-Lect-driven endocytosis disrupts mammary gland morphogenesis, induces epithelial-to-mesenchymal plasticity (EMP), and activates transcriptional programs associated with tissue remodeling and alveologenesis. These alterations synergize with the ERBB2/Neu breast oncogene to accelerate tumor onset and promote lung metastasis. Importantly, enhanced ECAD endocytosis was directly demonstrated in the intact mammary epithelium and shown to underlie the morphogenetic and invasive phenotypes. Pharmacologic inhibition of the GL-Lect mechanism suppressed ECAD internalization and reversed morphogenetic, polarity, and invasive phenotypes ex vivo, providing proof-of-concept for therapeutic targeting. These findings establish GL-Lect-driven endocytosis as a physiological regulator of mammary epithelial plasticity. When dysregulated, it drives metastatic progression and uncovers a tractable therapeutic vulnerability in breast cancer.
Authors: Amir Fardin(Investigation, Methodology), Andrea Francesco Benvenuto(Investigation, Methodology), Irene Schiano Lomoriello(Investigation, Methodology, Writing – review & editing), Chiara Tordonato(Investigation, Methodology, Writing – review & editing), Micaela Quarto(Investigation, Methodology), Stefano Freddi(Investigation, Methodology), Maria Chiara Rainone(Investigation), Giovanni Giangreco(Investigation), Giovanni Bertalot(Investigation, Methodology), Francesca Montani(Investigation, Methodology), Ivan Nicola Colaluca(Investigation), Roberta Cacciatore(Investigation), Andrea Raimondi(Investigation, Methodology), Maria Giovanna Jodice, Maria Grazia Malabarba(Writing – review & editing), Luigi Scietti(Investigation, Methodology, Resources), Giuseppe Ciossani(Investigation, Methodology, Resources), Alessandro Cuomo(Investigation, Methodology), Massiullah Shafaq-Zadah(Methodology), Estelle Dransart(Methodology), Sina Kanannejad, Brenda Green(Investigation, Methodology), Salvatore Pece(Funding acquisition, Investigation, Supervision), Stefano Confalonieri, Ulf J. Nilsson(Resources, Writing – review & editing), Hakon Leffler(Resources, Writing – review & editing), Giorgio Scita(Funding acquisition, Resources, Supervision, Writing – review & editing), Ludger Johannes(Funding acquisition, Resources, Supervision, Writing – review & editing), Pier Paolo Di Fiore(Conceptualization, Funding acquisition, Resources, Supervision, Writing – review & editing), Sara Sigismund(Conceptualization, Funding acquisition, Resources, Supervision, Writing – original draft, Writing – review & editing)
Institutions: European Institute of Oncology, University of Milan, The Francis Crick Institute, University of Trento, Institute for Research in Biomedicine, Università della Svizzera italiana, Centre National de la Recherche Scientifique, Inserm, Université Paris Sciences et Lettres, Chimie et Biologie de la Cellule, Institut Curie, IFOM, Lund University
Language: English
Subfield: Cell Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,790
Funders: Mizutani Foundation for Glycoscience, Università degli Studi di Milano, Agence Nationale de la Recherche, Fondation pour la Recherche Médicale, Ministero della Salute, Ministero dell’Istruzione, dell’Università e della Ricerca, Fondation ARC pour la Recherche sur le Cancer, Fondazione Umberto Veronesi, Associazione Italiana per la Ricerca sul Cancro, NextGenerationEU
Awards: G1109644443, G1121859892, G118936465, G1219903625, G1245818545, G1253938088, G1304975826, G1325846531, G1565939250, G1610081662, G1766259285, G1826279715, G1862186157, G1937840943, G1995339806, G2035622065, G231133531, G2370974534, G2484443933, G255694563, G2591692910, G287137354, G3800566186, G387172998, G4181944010, G4262869373, G4350852068, G4379363541, G4555414577, G4578720817, G490430286, G4949618088, Investigating the role of retrograde transport in T lymphocyte activation, G5315675380, G5472210570, G5507061752, G5589382580, G5911110335, G5914622547, G5922675872, G6070353463, G6229344744, G6328338962, Orientation microscopy and cryo-electron tomography to study glycan-dependent assembly of membrane nanodomains, Force nanosensor to measure membrane protein oligomerization, G6734493484, G69369748, G6981174239, G7424879168, G7962275750, G8175601399, G826124381, Glycan topology-switch of integrin activity, G872973519, G8909148363
OpenAlex ID: W7119536820
